Georgia Bio Names Ashley Williams Haltom New VP of Government Affairs

Ashley Williams Haltom headshot

Atlanta, Georgia (December 11, 2020) – Georgia Bio, the state’s public policy and business solutions organization representing Georgia’s life sciences sector, announced an addition to its team hiring Ashley Williams Haltom as the Vice President of Government Affairs. In this role, she will provide expanded leadership in developing and implementing sound public policy strategies for Georgia Bio members and strengthen the voice of life sciences in the state.

“At this critical juncture, life sciences play a more prominent role than at any point in recent history. My top priority is to provide information and resources to policymakers on Georgia’s life sciences ecosystem and the important role that it plays in our state,” said Mrs. Haltom.

As Georgia’s biotechnology, medical device, agbio, and digital health communities continue to grow, the addition of Mrs. Haltom bolsters the organization’s government relations activities. Those activities seek to drive solution-oriented public policies and advocacy that support life sciences research, investment and innovation in the state.

Mrs. Haltom has almost a decade of experience working in politics and government, serving in roles with then-Governor Deal’s Office of Workforce Development, the Georgia House of Representatives, and state and federal campaigns. Most recently, she served as the Communications Director and Staff Lobbyist for a statewide trade association. She is a graduate of the University of Georgia with a degree in International Affairs.

“This role, with ongoing support from our lobbyist Cornerstone Government Affairs, will deepen our relationship with policymakers,” said Maria Thacker Goethe, Georgia Bio’s president and CEO. “Ashley will enhance awareness at the state level for the contributions our life sciences sector and member companies make to Georgia’s economy and improvements in patient care. I am delighted to welcome her to Georgia Bio.”

About Georgia Bio

Georgia Bio ( www.gabio.org ) is the state’s private, non-profit life sciences association. Members include pharmaceutical, biotechnology and medical device companies, medical centers, universities and research institutes, government groups and other business organizations involved in the development of life sciences related products and services.

Media Contact:
Kristina Forbes
404-920-2043
kforbes@gabio.org

Georgia Life Sciences Joins National Coalition Urging Congressional Action on Key Innovation Policies

December 10, 2025
Georgia Life Sciences has joined 43 state and regional life sciences organizations in signing a national Council of State Bioscience Associations (CSBA) letter calling on Congress to take immediate action on three bipartisan policy priorities that are essential to sustaining U.S. leadership in biomedical innovation and supporting patients nationwide. With Congress back in session and several critical programs at risk of expiring, the letter urges congressional leaders to advance the following provisions without delay: 1. Reauthorize the Rare Pediatric Disease Priority Review Voucher (PPRV) Program The PPRV program has been instrumental in incentivizing the development of therapies for children with rare and life-threatening conditions. Its lapse threatens to slow or halt research that families across the country are counting on. 2. Extend the SBIR/STTR Programs The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs provide crucial early-stage capital for emerging biotech and medtech companies—many of them in Georgia. Without reauthorization, hundreds of innovative small businesses face uncertainty, jeopardizing new therapies, diagnostics, and technologies in the pipeline, 3. Advance PBM Transparency Reforms Greater transparency and accountability within pharmacy benefit manager (PBM) practices are needed to ensure that savings reach patients and employers. Reforming PBM operations is essential to strengthening access and affordability across the healthcare system. A Unified Message from the Life Sciences Community The sign-on letter reflects broad, bipartisan alignment across the national life sciences ecosystem: researchers, entrepreneurs, investors, patient advocates, and state associations all share a common message— these programs underpin America’s global competitiveness and are vital to patients who rely on continued scientific progress. Georgia Life Sciences has shared the letter with members of Georgia’s congressional delegation and will continue engaging with policymakers to emphasize the importance of swift action.

GLS Joins Georgia Partners in Calling for Federal PBM Reform

December 7, 2025
Georgia Life Sciences is proud to stand with patient advocates, providers, and employers across the state in urging Congress to take meaningful action on pharmacy benefit manager (PBM) reform. We recently signed on to a joint letter to Georgia’s Congressional Delegation stressing the urgent need for transparency, fair practices, and policies that ensure savings flow directly to patients.

GLS’ President and CEO, Maria Thacker Goethe in December's issue of Georgia Trend

December 4, 2025
Georgia Life Sciences’ CEO, Maria Thacker Goethe shares her perspective on the value of Georgia’s research universities in this month’s issue of Georgia Trend. “Georgia research institutions have felt a very significant impact from the federal rollbacks, specifically in NIH and NSF funding. Thacker Goethe’s message about the impact of research cuts is simple: Disruption shatters the foundational trust researchers have in grant continuity….” To read the full article, click here .
MORE POSTS